• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
Smith+Nephew's RI.HIP NAVIGATION
Pin It

Smith+Nephew (LSE:SN,NYSE:SNN), the global medical technology business, the expansion of indications on its CORI Surgical System.

The industry's most advanced and efficient1,* handheld robotic solution in total knee arthroplasty1,*,† - to now include total hip arthroplasty (THA). Smith+Nephew's RI.HIP NAVIGATION - designed to help maximize accuracy and reproducibility by delivering patient-specific component alignment for THA – is now available for use on its CORI System.

Last year, a new study concluded that computer-guided technology for THA significantly reduced the risk of revision2 and increased patient satisfaction2 when using Smith+Nephew implants.

The first of its kind study used data from the world's largest arthroplasty register (National Joint Registry of England, Wales and Northern Ireland) to investigate the effect of computer-guided THA surgery on implant survivorship.2 The data reported on THA surgery performed using Smith+Nephew hip replacement components implanted for osteoarthritis since 2003 and was presented at the 2021 World Arthroplasty Congress. The results demonstrated:

    A significantly lower revision rate at 10 years with computer-guided (1.06%) vs. conventional THA (3.88%; p=0.005)2
    A 55% lower risk of revision at 10 years with computer-guided vs. conventional THA (p=0.038)2, and
    Significantly higher patient satisfaction in the computer-guided group compared to conventional THA (p=0.003)2

"The addition of RI.HIP NAVIGATION on the CORI System further strengthens Smith+Nephew's Real Intelligence digital ecosystem and underscores our commitment to advancing clinical outcomes in total hip arthroplasty," said Randy Kilburn, Executive Vice President & General Manager, Reconstruction, Robotics and Digital Surgery for Smith+Nephew.

"We look forward to offering the possibility of further improving patient outcomes and satisfaction to a broader surgeon community with the rapidly expanding adoption of our CORI Surgical System."

Smith+Nephew's RI.HIP NAVIGATION recently received 510(k) clearance from the United States Food and Drug Administration for use on its CORI Surgical System. Software installations will start immediately for a limited number of hospitals and Ambulatory Surgery Centers (ASCs) in the United States with broad commercial availability later in 2022. It will be introduced in various European and Asia Pacific markets once regulatory authorizations are finalized.

1. Smith+Nephew 2020. CORI and NAVIO System Technical Specification Comparison. Internal Report. ER0488 REV B.

2. Davis ET, McKinney KD, Kamali A, Kuljaca S, Pagkalos J. Computer guided total hip arthroplasty is associated with a reduced risk of revision and increased patient satisfaction. An analysis of a single manufacturer acetabular components from the National Joint Registry of England, Wales, Northern Ireland and the Isle of Man. Poster presented at: World Arthroplasty Congress Virtual Meeting; April 22-24, 2021

For more information please visit www.smith-nephew.com

Company Name: Smith & Nephew plc
About Company: Smith+Nephew is a portfolio medical technology business focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people's bodies and their self-belief by using technology to take the limits off living. We call this purpose 'Life Unlimited'. Our 18,000 employees deliver this mission every day, making a difference to patients' lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global franchises of Orthopaedics, Advanced Wound Management and Sports Medicine & ENT. Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of $4.6 billion in 2020. Smith+Nephew is a constituent of the FTSE100 (LSE:SN,NYSE:SNN). The terms 'Group' and 'Smith+Nephew' are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.